Clinical Trials Directory

Trials / Completed

CompletedNCT05667961

Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation

Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation: a Case-control Study

Status
Completed
Phase
Study type
Observational
Enrollment
480 (actual)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Study objectives: 1. Describe the characteristics of discharged patients with schizophrenia achieving functional remission after drug discontinuation. 2. Establish a prediction model of patients with schizophrenia having good prognosis after drug discontinuation.

Detailed description

There are 2 clinically important and urgent questions to be explored in this study: 1. Who is more likely to benefit from guided drug reduction or discontinuation? How to design an individualized treatment plan which can balance the risk of relapse and side-effects from antipsychotics? 2. What are the predictors of functional remission in patients with schizophrenia after drug discontinuation? This will be the first related study to be conducted in China.

Conditions

Timeline

Start date
2022-09-15
Primary completion
2025-01-31
Completion
2025-03-31
First posted
2022-12-29
Last updated
2025-04-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05667961. Inclusion in this directory is not an endorsement.

Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation (NCT05667961) · Clinical Trials Directory